[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2013 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- 12.24%
YoY- -50.63%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 1,606,206 1,509,162 1,495,830 1,378,779 1,329,942 1,153,195 1,002,232 8.17%
PBT 67,948 89,005 87,726 59,990 99,066 56,818 48,163 5.89%
Tax -21,189 -20,462 -30,122 -24,496 -28,392 -16,215 -15,901 4.89%
NP 46,759 68,543 57,604 35,494 70,674 40,603 32,262 6.37%
-
NP to SH 46,435 67,982 57,147 34,387 69,645 40,215 32,640 6.04%
-
Tax Rate 31.18% 22.99% 34.34% 40.83% 28.66% 28.54% 33.01% -
Total Cost 1,559,447 1,440,619 1,438,226 1,343,285 1,259,268 1,112,592 969,970 8.22%
-
Net Worth 530,907 534,070 507,513 473,857 496,623 464,307 424,715 3.78%
Dividend
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Div 33,667 59,542 41,429 25,427 29,420 - 50,281 -6.46%
Div Payout % 72.50% 87.59% 72.50% 73.95% 42.24% - 154.05% -
Equity
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Net Worth 530,907 534,070 507,513 473,857 496,623 464,307 424,715 3.78%
NOSH 258,979 258,880 258,935 258,938 117,683 106,983 106,981 15.86%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 2.91% 4.54% 3.85% 2.57% 5.31% 3.52% 3.22% -
ROE 8.75% 12.73% 11.26% 7.26% 14.02% 8.66% 7.69% -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 620.21 582.96 577.69 532.47 1,130.10 1,077.92 936.83 -6.63%
EPS 17.93 26.26 22.07 13.28 59.18 37.59 30.51 -8.47%
DPS 13.00 23.00 16.00 9.82 25.00 0.00 47.00 -19.26%
NAPS 2.05 2.063 1.96 1.83 4.22 4.34 3.97 -10.42%
Adjusted Per Share Value based on latest NOSH - 258,689
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 111.45 104.71 103.79 95.67 92.28 80.01 69.54 8.17%
EPS 3.22 4.72 3.97 2.39 4.83 2.79 2.26 6.07%
DPS 2.34 4.13 2.87 1.76 2.04 0.00 3.49 -6.43%
NAPS 0.3684 0.3706 0.3521 0.3288 0.3446 0.3222 0.2947 3.78%
Price Multiplier on Financial Quarter End Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 -
Price 5.58 6.50 4.63 4.82 7.55 5.90 4.98 -
P/RPS 0.90 1.12 0.80 0.91 0.67 0.55 0.53 9.21%
P/EPS 31.12 24.75 20.98 36.30 12.76 15.70 16.32 11.34%
EY 3.21 4.04 4.77 2.76 7.84 6.37 6.13 -10.21%
DY 2.33 3.54 3.46 2.04 3.31 0.00 9.44 -20.78%
P/NAPS 2.72 3.15 2.36 2.63 1.79 1.36 1.25 13.82%
Price Multiplier on Announcement Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 21/11/16 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 -
Price 5.70 6.50 4.45 4.72 8.25 5.90 4.92 -
P/RPS 0.92 1.12 0.77 0.89 0.73 0.55 0.53 9.61%
P/EPS 31.79 24.75 20.16 35.54 13.94 15.70 16.13 11.96%
EY 3.15 4.04 4.96 2.81 7.17 6.37 6.20 -10.66%
DY 2.28 3.54 3.60 2.08 3.03 0.00 9.55 -21.21%
P/NAPS 2.78 3.15 2.27 2.58 1.95 1.36 1.24 14.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment